The UK’s leading free-to-attend conference & exhibition for diabetes healthcare professionals
DPC2018 is kindly supported by:
Novo Nordisk is a global healthcare company with a record of 90 years of innovation and leadership in diabetes care. Read more
DRWF is registered charity (no. 1070607) established in 1998 to raise awareness to Type 1 and Type 2 diabetes; to provide Read more
For over 30 years we have been helping healthcare professionals achieve benefits from healthcare technology. Our software is designed to improve the efficiency and reliability of healthcare processes and to deliver accurate data that improves clinical and operational decision making.
Our web-based diabetes patient management solutions allow healthcare professionals to accurately capture, record and report a wide range of diabetes patient data, and have the ability to access information wherever and whenever there is patient interaction, including community based services that are a vital component of an effective model of integrated health and social care.
Ascensia Diabetes Care are pleased to part of Diabetes Professional Care 2016 where we will be demonstrating the NEW CONTOUR® NEXT ONE blood glucose monitoring system, the next exciting development in the evolution of self-monitoring of blood glucose for people with diabetes.
We believe that the CONTOUR® NEXT ONE blood glucose monitoring systems can be a significant advance for people with diabetes. These systems combine the remarkable accuracy of our CONTOUR® NEXT meter platforms with the easy-to-use features of the CONTOUR® Diabetes App to provide insights that help patients to better manage their condition. These systems enable people with diabetes to learn more about their condition and make the appropriate management decisions.
Advanced Therapeutics (UK) Limited (ATUK) are a UK wide distributor of specialist medical devices that meet real clinical needs, simplify therapy and improve quality of life.
ATUK are the exclusive UK Distributor for the Dario All-in-One Smart Meter, which offers:
Compact easy to carry and discreet design
Hypo Alert System for loved ones & care providers
Convenience and ease-of-use
Insulin bolus calculator
Use of existing smart devices (Android/IOS)
Remote sharing of Blood Glucose results
Exceeds new accuracy standard ISO 15197:2013
Cambridge Weight Plan manufactures formula food products used in total diet replacement regimens providing energy intakes both under 800kcal/d and above 800kcal/d. Collaboration with research scientists has generated gold-standard evidence for effective weight loss and maintenance, safety, improved nutritional status and improved cardiovascular risk status. Programmes can be delivered by trained Cambridge Consultants working in a community setting or by health care professionals and deliver average weight losses of over 10kg of body weight and weight maintenance for up to four years, with improved nutritional status, and health benefits in osteoarthritis, psoriasis, obstructive sleep apnoea, coronary artery disease and diabetes.
BD Diabetes Care – “Beyond just the provision of Pen Needles”
BD are thrilled to be supporting the Diabetes Village at Diabetes Professional Conference. Since 1924, when BD launched the world’s first insulin syringe to accompany insulin injection, the mission has been clear: to consistently innovate, improve and support, both patients and healthcare professionals with the best injection experience possible. BD welcome the opportunity to share our latest solutions involving; Intensive support and management of the patient injection – with BDandME™ and how transitioning to lower price pen needles, does not necessarily mean any compromise on quality! – come and view and collect samples of our newly launched pen needle – BD Viva™.
All this and…. an opportunity to collect a copy of the new 4th Set of FIT Recommendations, to read whilst sipping a freshly ground Latte or Cappuccino! Looking forward to seeing you there!
Loic Herve, Business Director UK - BD Diabetes Care
Novo Nordisk is a global healthcare company with a record of 90 years of innovation and leadership in diabetes care. We also have leading positions within haemophilia care, growth hormone treatment and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries. Every day, millions of people all over the world rely on our products, which are manufactured in seven countries.
Over the past 90 years, our researchers have pioneered many breakthroughs in its management, and today, our determination to help these people is stronger than ever.
Besins Healthcare is a pharmaceutical company specialising in the development of innovative drugs for the well-being of men and women throughout their life.
Over the last 30 years, Besins has established a strong and reputable name in the production of drugs for the treatment of gynaecological, fertility and obstetrical conditions as well as androgen deficiency and has become a renowned player in the area of hormonal therapies.
Besins global commercial operations is based in the UK and our drugs are distributed in more than 90 countries via subsidiary companies (Besins affiliates) as well as a network of business partners. Besins is actively pursuing new growth opportunities through acquisition and expansion into new territories, bringing significant growth over the coming years.
Besins products are manufactured in a number of countries including France, Belgium and Spain.
To ensure we meet the needs of tomorrow, Besins has two primary care research and development facilities across the globe. One of our research facilities is Laboratories Besins International, located in France, the other is BHR Pharma, USA, which is an affiliate of Ascend Therapeutics, Inc.
DRWF is registered charity (no. 1070607) established in 1998 to raise awareness to Type 1 and Type 2 diabetes; to provide information and support to people living with the conditions and to fund research to establish causes, treatment, management and ultimately, to find a cure.
Supported self-management is key to achieving the best possible results. Life with diabetes presents many challenges which require collective solution finding and we provide opportunities for those living with, and working in the field of diabetes and related health, to come together within a like-minded community to tackle those challenges together.
We are delighted to support DPC 2016 as an initiative that reflects our own thinking.
Servier Laboratories is the UK subsidiary of The Servier Research Group, a French research based pharmaceutical company established in 1954 by Dr Jacques Sevier. Created in 1963 with only two people, the UK subsidiary was the first subsidiary outside France. In just over fifty years, The Servier Research Group has developed in stature from a small family-owned, provincial pharmacy employing nine people to a multi-national operation, established in 140 countries. As an independent research foundation, with no shareholders, Servier has the freedom to be guided by clinical and patient need. Profits from the sales of our medicines are reinvested to fund research and the development of tomorrow's innovative medicines. Servier is focused on research and partnerships in the fields of cardiology, diabetes, rheumatology, neurology and oncology.
Pioneers in Diabetes Care, Abbott Laboratories, are presenting the innovative FreeStyle Libre flash glucose monitoring system new research and latest innovation at the show. Amongst the great number of interesting sessions will be Paediatrician and Diabetologist consultant Dr Fiona Campbell , who will be presenting a symposium on Thursday 17th November at 10:05am on the topic “Dare to Dream? There’s an App for that: What we are learning from the next generation”.
Established in 1990, BHR Pharmaceuticals Ltd has become a market leader in the provision of point-of-care diagnostics. BHR specialises in sourcing new progressive technology from around the world and delivering these innovative products to the UK market.
Our product range is based around ease of use, improving diagnosis times, and monitoring of chronic conditions at point-of-care. BHR aims to make diagnostics more accessible and affordable for use in a multitude of settings.
We believe in giving customers the best possible support and after sales care, providing full access to our dedicated and experienced customer service and technical support teams.
Diabetes Professional Care
+44 23 8081 1551
Wednesday 14 November 2018
Thursday 15 November 2018